Ghrelin (Ghrl), a 28-amino acid orexigenic peptide with a molecular weight of approximately 3.4 kDa, has been investigated as a therapeutic agent for the management of cachexia due to its orexigenic, anabolic, and inflammation-modulating effects. The gene discussed is GHRL; the disease is Cachexia.